Baronova secures $7.5 million in Series B funding - MarketLine Financial Deals

Baronova secures $7.5 million in Series B funding

3 pages — Published Oct 23, 2008
Price $45.00  |  Buy this Report Now

About This Report

  
Abstract:

Baronova, Inc., a US-based developer of nonsurgical and nonpharmacologic therapies to treat obesity, has secured $7.5 million in Series B funding round led by Allergan, Inc. Existing investors Arboretum Ventures, Highland Capital Partners and Onset Ventures are also participated in the funding round.

  
Source:
Document ID
MA00316_081025
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Baronova secures $7.5 million in Series B funding" Oct 23, 2008. Alacra Store. Apr 16, 2014. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Baronova-secures-7-5-million-in-Series-B-funding-2052-256>
  
APA:
MarketLine Financial Deals. (2008). Baronova secures $7.5 million in Series B funding Oct 23, 2008. New York, NY: Alacra Store. Retrieved Apr 16, 2014 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Baronova-secures-7-5-million-in-Series-B-funding-2052-256>
  
$45.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.